In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Sana Biotechnology (SANA – Research ...
On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.39 which represents a decrease of $-0.37 or -9.84% from the prior close of $3.76. The stock opened at $3.5 and ...
Fintel on MSN1d
JMP Securities Downgrades Sana Biotechnology (SANA)Fintel reports that on November 5, 2024, JMP Securities downgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) from ...
About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 ...
JMP has downgraded Sana Biotechnology (NASDAQ:SANA) to market perform from market outperform, citing uncertainty surrounding ...
Just three years removed from a lucrative IPO, the company will cut jobs for a third time and invest more heavily in cell ...
JMP Securities downgraded Sana Biotechnology (SANA) to Market Perform from Outperform without a price target after the company announced a ...
Sana Biotechnology is pruning its pipeline and headcount for the second time in around a year to stretch its cash and ...
Sana Biotechnology has become the latest cell therapy biotech to shift resources from cancer to autoimmune diseases as part of a ...
PARSIPPANY, NJ, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. ("Interpace” or the "Company”) (OTCQX: IDXG) today announced financial results for the third quarter ended September 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback